Full industry-pushing agenda

Where pharma comes to life

9:30am–9:55amMonday

Give life: an industry at the beginning of its potential

  • From chemicals, to biologics, to gene/cell therapy: how our treatments are becoming more lifelike and provide opportunities to transcend our place in the healthcare hierarchy
  • Why the time is right to act on digitizing development through preparation of a superior mix of virtual trials and regulatory-grade RWE

9:30am–9:55amMonday

Authenticity as the pinnacle of pharma leadership

  • Bring accuracy in decision-making and portfolio design through the combining of multiple data sources into an intelligent narrative
  • Why trust must be tackled to enable alignment with your patient community and a continuous flow of real-time patient insight
  • The drive for medically-sound content and engagement as we rewrite our customer relationships

9:30am–9:55amMonday

A new definition of disease means a new definition of treatment

  • With improved understanding of molecular, digitally-enabled pathology, expand your portfolio to an excitingly diverse range of new breakthroughs
  • Improve clinical trial rates and overall productivity through using fewer patients to get meaningful outcomes.
  • Change the narrative with physicians to enable screening for genetic mutations and enable precision medicine to become reality

9:30am–9:55amMonday

A digital business model: how fusing clinical and real world data can generate new product types

  • Make data a real asset: how Sanofi intends to use new data insights that develop top-line revenue in the form of new products
  • Harness endpoints previously not in existence through novel data collection, analytics and methods
  • Achieve ambitions through partnership with major tech companies – without ceding control and ownership of core capabilities

9:30am–9:55amMonday

A new open evidence standard

  • The goal isn’t regulatory approval. The goal is to improve human health. How pharma companies need to make breakthroughs accessible
  • Beyond corporate secrecy: sharing science and defragmenting data to lower the cost of research for all
  • Work with physicians and EHRs in development to leverage big data and progress in studying diseases with efficient, universal protocols

9:30am–9:55amMonday

Take responsibility for pricing – and lower your costs

  • Why executives must take ownership of their prices – and seize control of the pricing debate
  • Jump, don’t be pushed: reform your greatest cost centres in clinical and commercial to make lower pricing a possibility

9:30am–9:55amMonday

Why pharma is perfect for predictive intelligence

  • Understand the greatest reasons why you should take advantage of the 2314 exabytes of health data being produced in 2020
  • AI as your friend: how to deploy data lakes in an effective manner to reveal genuinely actionable insights

9:30am–9:55amMonday

PANEL: Silicon Valley is coming: the tidal wave of digital health entrepreneurs and how to combine forces

  • How incubators can really work in pharma – lessons from first-mover innovation labs and health hubs and impact on core company culture
  • Scouting disruption: how to identify the companies to partner with, work in with agility and scale beyond pilot
  • The innovations from big tech (Google, Apple) including ServiceKit and other democratizing patient tools

9:30am–9:55amMonday

Value-based healthcare: a critical review

  • An objective view into who is really making progress with beyond the pill innovation, has evidence and can project payer support
  • Enable higher standards and better cross-country / cross-system sharing to bring
  • How to support necessary ecosystem developments, including internationally-linked disease registries

9:30am–9:55amMonday

Every Life is Equal: how innovation in access is the world health’s greatest opportunity

  • Demography is destiny: why Africa’s health needs are a worthy challenge for every pharma executive and a purposeful vision for pharma
  • Infrastructure as the answer to improved health and the role we have in building sustainability
  • How to de-silo innovation so that we can take advantage of a new generation of medicines suited to disease like malaria and polio

9:30am–9:55amMonday

PANEL: Eye of the tiger: why Asian startups will redefine your business in the next 5 years

  • Health and tech are converging in unprecedented ways across the Asia Pacific region to the tune of over $6bn invested annually. How conscious are you of the impending innovation?
  • Find reference points for your innovation teams and harness the products and processes being generated

9:30am–9:55amMonday

Humanity+ as a new goal for patients

  • Evolve from sickcare into healthcare and focus on making humans better than they began
  • The road from early detection to prevention: how to get new types of treatment into reality
  • Curing ageing as the answer to solving multiple disease threats

Accomplish cultural transformation

9:30am–9:55amMonday

Case Study: How to initiate an effective turnaround plan that cascades through your business

  • Identify the obstacles you face when changing your core business model and how to overcome them
  • See the process Allergopharma used to identify the best of commercial pharma which it wanted to adopt – and the areas that were avoided

9:30am–9:55amMonday

Create a holistic customer experience: break down silos to harness the combined power of commercial capabilities and medical authenticity

  • See the whole customer journey by aligning commercial and medical teams under one overarching engagement strategy, across all field and digital initiatives
  • Why education principles and disease led strategy are crucial to successful collaboration
  • Redefine “a good customer relationship” by leveraging combined insights and capabilities without tarnishing the valued authenticity of an independent medical affairs

9:30am–9:55amMonday

Spark a cultural revolution through a purpose-led digital strategy, accelerating digital adoption throughout your organisation

  • Encourage greater digital implementation amongst laggard teams by using metrics and KPIs that more tangibly demonstrate long-term impact
  • Create a global strategy that evolves to meet local affiliate constraints and specific customer requirements, whilst reducing duplication of effort

9:30am–9:55amMonday

Google’s challenge to pharma: A new patient privacy policy standard for 2020 and beyond

  • How digital health and patient privacy is evolving from the Google Perspective
  • Innovative ways for health-tech to operate within the new privacy state

Beyond traditional marketing

9:30am–9:55amMonday

Case Study: Almirall’s Digital Garden that partners with start-ups to innovate together

  • Provide start-ups with the nutrients they need to grow into the next digital disruptor
  • Co-create cutting edge digital solutions when you provide pioneering start-ups leveraging pharma expertise
  • Learn how you can streamline your own operations through symbiotic sharing of information and processes

9:30am–9:55amMonday

Case Study: Beyond the medicine: Co-creating solutions that meet real world patient and HCP needs

  • Explore 3 projects from Roche Innovation Lab and hear about the journey behind each project from first interaction to final solutions
  • Understand how each solution delivers value to the users by getting insights in user feedback and Roche’s learnings

9:30am–9:55amMonday

Empower commercial decision-making: Bring data from every interaction together

  • Define your digital investment strategy by creating a continuous feedback loop of engagement activity
  • Give reps and marketing strategists the advantage with a backbone infrastructure that links together separate systems, spreading of insights and data throughout the business

9:30am–9:55amMonday

Case Study: Why disease strategy trumps brand strategy

  • See the enormous patient outcome and reputational benefits of focusing on improving therapeutic area care alongside drug provision
  • Explore the long-term business case for forgetting about the brand

9:30am–9:55amMonday

Create a social strategy that delivers across all age populations

  • Across demographics HCPs and patients are changing how they are connecting and self-educating
  • Understand your audience to create connections
  • See how a mixed social influencer strategy with advocacy partnerships helps to scale outreach

9:30am–9:55amMonday

Closed-loop marketing: An integrated channel approach for consistent success

  • Ensure marketing, IT and external alignment to make sure capabilities are there to back-up marketing innovations
  • Make informed channel and content selection decisions by creating a backbone infrastructure that allows data flow across the company

Deliver personalised CX

9:30am–9:55amMonday

Deliver a personalised customer experience

  • Use marketing automation to create memorable customer journeys through the most relevant channels
  • Further improve CX by gathering and analysing data seamlessly through an integrated platform

9:30am–9:55amMonday

Case Study: Walk in your customer’s shoes: understand every step of the customer journey to provide personalised CX

  • Build a complete picture of your customer by tracking all interactions, not just those with your own brands
  • Focus on the motives of your physicians’ actions to ensure you provide the service they need most effectively

9:30am–9:55amMonday

Case Study: Adopt human-centered design. Achieve optimal customer experience.

  • Understand how a “human-first” cultural ethos was implemented, and practicalities of maintaining this whilst scaling up
  • Achieve sky high retention rates with an online CX combining behavioural science, with digital and traditional support methods
  • Digital isn't always right: Examples of how this approach led to a variety of patient and HCP solutions driven by customer understanding, not technological availability

9:30am–9:55amMonday

Differentiate your product with value-added services through user-centric design

  • Learn how to drive adoption by differentiating your value-added programs in an often-saturated environment
  • Design fit-for-purpose services and ensure sustained use by engaging in co-creation with HCPs and/or patients throughout service development

The multichannel fieldforce

9:30am–9:55amMonday

Case Study: The HCP-KOL matchmaker - Janssen’s new portal connecting HCPs with experts across healthcare

  • Satisfy HCPs craving for knowledge by providing a non-monitored environment for expert interaction
  • How Medical and commercial collaboration ensured scientific value for customers, whilst maintaining clear ROI

9:30am–9:55amMonday

Create an adaptive field force to meet customer expectations in the digital world

  • Find balance between virtual engagements and infield activity to ensure relationship building remains personal
  • Optimise rep engagement by ensuring the value of digital capabilities is clearly demonstrated, fostering greater transformation
  • Define the evolving role of the rep in the era of increased medical engagement, whilst increasing collaboration to create a seamless customer experience

Organisational empowerment

9:30am–9:55amMonday

Get your organisation on the same page

  • Success starts at home – how to put in place strong internal networks that make external operations seamless
  • Why you need to determine what patient centricity is to your organisation and make sure that culture and strategy is being infused across all functions

9:30am–9:55amMonday

Make patient engagement your new normal

  • Consistently be meeting best practice guidelines for systematic, meaningful patient engagement
  • Stay ahead of the game: Demand engagement to keep your competitive advantage as regulators signal a shift to making it expected
  • The Legal & Compensation Conundrum: How to derive fair market value for your patient network and set reasonable legal agreements to keep them coming back and contributing

9:30am–9:55amMonday

Panel: No trust, no data? No pharma. Create a patient data research opportunity through education and collaboration #DataSavesLives

  • Case Study: How the new #DataSavesLives EPF initiative is improving patient perspectives on data use by providing complex information in an understandable and accessible way
  • Understand the importance of trust in improving data sharing attitudes as patient ownership increases

Propel patient-led deisgn

9:30am–9:55amMonday

Know your audience: develop tools that patients can understand

  • Drastically improve your educational tools by engaging the right patients to establish where their knowledge gaps are and how to fill them
  • The simpler, the better: ease HCPs' workload by developing materials that make delivery seamless and help patients articulate their needs

9:30am–9:55amMonday

Challenge the ‘old pharma’ mindset with evidence-based outcomes

  • Empower the patients voice in-house and convince all functions of its value by developing measurable insights
  • Break down silos to swiftly incorporate the patient’s perspective when developing new services

9:30am–9:55amMonday

If you think you’re patient-centric, you’re probably only halfway there

  • Case Study: How Novo Nordisk developed next generation support programmes by engaging their patient partners to identify and then solve critical unmet needs for those with diabetes
  • Learn from your mistakes: An honest assessment of how to identify flaws in your frameworks when approaching patient support in different socio-economic, cultural and healthcare systems

Insight driven patient-centricity

9:30am–9:55amMonday

Case Study: Syntropy – safeguard data ownership and foster cancer-care and research through an advanced analytics platform

  • Build a network of researchers and organisations to drive scientific discovery and enable better care for patients
  • Waiting for more details on case study

9:30am–9:55amMonday

Not just lip service but real results

  • Examine why AstraZeneca created a strategy for growth by connecting innovation to patient centricity
  • Case Study: Discover-NOW; how this new collaborative innovation-hub will gather real world evidence to better monitor and manage patients with Type-2 Diabetes

9:30am–9:55amMonday

Payers and patients: Raise the engagement bar for a smooth approval process

  • As payers shift from efficacy to PROs and beyond, see why defining what is important to patients is becoming essential for access
  • Experience is just as important as the outcomes; exploring how to engage with the right patients in the right way to ensure you are capturing the relevant insights
  • Why having a pro-active and constructive dialogue with patients, regulators and payers is key to securing access

Collaboration Evolution

9:30am–9:55amMonday

The future is collaborative: How open innovation can enable patient-centric research

  • Understand how trust, mutual benefits and transparency can truly change the collaboration model
  • Explore how to engage a network of scientifically minded patients who can drive a new era of open innovation in R&D
  • Deliver patient relevant solutions by bridging the language gap between insights and research activities

9:30am–9:55amMonday

Partner up: Lessons for long-term collaboration

  • Move past the money; why you need to shift away from a purely transactional relationship if you want to create a true collaboration
  • How to align expectations from the outset to prevent likelihood of problems
  • Trust, transparency and respect – buzzwords or the foundation to better relationships with patients

9:30am–9:55amMonday

Panel: We all have a shared interest; better healthcare for patients

  • From small through to global organisations; discover what is best practice for engaging patient groups with various capabilities
  • You’re on the frontline, so lead from the front; why those in patient-centric roles must be the patients champion internally
  • The future is now: Understand how to pave the way for a new era of collaboration

Diversification, leadership and authenticity: Medical affairs beyond 2020

9:30am–9:55amMonday

Drive value – the evolving strategic role of medical affairs

  • Connect science, clinical outcomes and patient value build a Medical function ready for 2020 and beyond
  • Build a positive external reputation by driving scientific communications and dialogue with an ever-expanding external stakeholder network
  • Identify, optimise and integrate insights into internal teams to support planning, inform strategy and enhance value delivery

9:30am–9:55amMonday

Future-proof medical affairs: How to evolve into an agile, customer-driven function

  • Medical Governance frameworks to structure around the customer, internal and external, to co-create and present value
  • Excel in an algorithm and data driven healthcare decision-making system

9:30am–9:55amMonday

Empower your medical field force and fulfil stakeholder need

  • Don’t limit your MSLs to HCPs: define their new role on the frontline of pharma’s field force expanding across patient groups and market access authorities
  • MSLs aren’t superhuman: help them realise their full potential with a clear overall field-team strategy, whilst building capabilities in key business operational and soft skills
  • Ensure MSLs are not tongue-tied with a defined company compliance and medical governance framework

9:30am–9:55amMonday

Panel: Conduct your evidence symphony - a new paradigm to align cross-company evidence generation around outcomes

  • Better identify study gaps and requirements with Medical becoming the transceiver of scientific information across RWE studies and clinical trials
  • Why every company should centralise company evidence generation strategy to be led by Medical Affairs

9:30am–9:55amMonday

Achieve 360° measurement into the patient and physician impact of medical activities

  • Cost effective ways to measure and understand customer behaviour change
  • Adopt non-traditional metrics that more accurately represent medical’s unquantifiable and non-commercial value

Drive medical authenticity with digital

9:30am–9:55amMonday

Case study: Enlighten medical decision-making with an integrated insights system

  • How to implement an insights system that collates insights from across the company to make easily navigable / comprehendible
  • Provide more personalized value with more informed business decision-making, such as HCP targeting and content generation, better meeting stakeholder need
  • Ensure systems are purpose led, not technology

9:30am–9:55amMonday

Multi-case study session: Drive medical excellence with novel digital application

  • Maximise limited physician interaction time with data informed field force decision-making and content generation
  • Create new key stakeholder engagement opportunities with a focus on push over pull, using new technologies to catalyse HCP interactions across the customer journey
  • Provide medical education through virtual channels to increase efficiencies and reduce customer burden

The real-world data jigsaw: Let’s put the pieces together

9:30am–9:55amMonday

Generate trust between pharma and healthcare – the power of real-world data

9:30am–9:55amMonday

Case Study: Global real-world data: Experience from combining US and EU wide common data models for research objectives

  • How the CPRD are bridging the divide between the FDAs Sentinel Programme and IMI EHDEN’s common data to find new internationally linked patient understanding

9:30am–9:55amMonday

Case study: CAT: Aligning regulatory and HTA decision-making around RWE assessment

9:30am–9:55amMonday

DATA HARMONY: Enhancing patient care and R&D decision-making through big data integration across Europe

  • How the IMI Harmony data platform overcome data access, harmonisation and privacy challenges to integrate clinical, genome and registry data to enhance Hematology patient journey understanding
  • Future process to enable synthetic control armed trials, improving patient representation and study opportunity, through greater RWD source integration

9:30am–9:55amMonday

Panel: Amplify research opportunities with integrated RWD systems – learning from IMI’s BD4BO

  • How IMI’s EHDEN project is progressing in building a federated data networking across Europe using a common model, with key achievements and objectives
  • How the PIONEER initiative is creating a standardised data platform for prostate cancer, combining clinical and RWD sources, to enable greater therapeutic area research capabilities
  • Why standardisation is key in a world of linkage and AI/ML capabilities, and how these different approaches work in unison
  • Ensure data availability - approaches to increasing data holder’s willingness to share centralised data

The RWE Regulatory Revolution

9:30am–9:55amMonday

Expand your RWE horizon: The regulatory precedent for RWE submission

  • Overview of the latest guidance and legislation such as the FDA’s RWE Framework, EMA’s recent Regulatory Science to 2025 and the MHRA’s Early Access to Medicines Scheme - plus notable global perspectives
  • The core principles behind making RWD usable in regulatory submission

9:30am–9:55amMonday

Case study: Achieve RWE-only regulatory label expansion

  • Why an RWE-only submission strategy meant lower costs and overall faster approval process in comparison to the traditional study process
  • Agree on study design and methodology with early regulatory engagement
  • How to ensure regulatory-standard RWD - the steps taken to ensure data sources were appropriate and of high quality, ensuring credibility

9:30am–9:55amMonday

Illuminate trial design in early development with RWE

  • Educate internal teams on RWE use possibilities and the capability requirements to set-up to foster greater adoption of RWE resource
  • Increase evidence-based decision making in site location and patient identification, creating more efficient trials whilst improving study findings

9:30am–9:55amMonday

Panel: Generate RWE pre-approval to expand access and better inform pricing negotiations

  • Better inform dossier submissions with new forms of evidence, such as comparative efficacy and cost to hospital, not traditionally part of RCT’s scope with concurrent RWE studies
  • Gain internal buy-in by working with regulators to inform evidence collection and use strategy
  • Discuss next steps toward a new development paradigm with normalised RWE generation inclusion and reduced RCT reliance

Viva la market access revolution – systematic change in Europe

9:30am–9:55amMonday

Foresight into Trump’s unknown: Impact of the US drug pricing crisis in Europe

  • Assessment of pricing implications for the European market access system
  • Update on new, proposed and predicted legislative changes

9:30am–9:55amMonday

Improve productivity of market access efforts through joint-international procurement

  • Align international access strategies to reduce duplication

9:30am–9:55amMonday

Panel: HTA alignment – making European market access efficient

  • See the stakeholder engagement process behind the first successful joint HTA appraisals and price negotiations
  • Discuss how to reduce duplication of effort and ensure joint international assessment will translate into patient access on a local level
  • Understand what Common European Assessment models are proposed and how you can engage with their development

Maximise your data assets – find new insights and create more credible evidence

9:30am–9:55amMonday

Rejuvinate your data - use deep learning to improve data asset ROI

  • Find actionable insights to inform research decision-making by using machine/deep learning to rediscover your existing datasets
  • Avoid bias in your algorithms – the need for optimal source data and methodologies

9:30am–9:55amMonday

Case Study: Novartis’ AE Brain - AI that predicts adverse events and product complaints from your digital channels

  • Use AI to identify potential safety cases and product technical complaints across your complete digital channel spectrum, including chatbots, CRM notes, social media, apps and email. And its GxP too
  • Scale Xperience: A novel solution to scaling in a global enterprise solving compliance barriers, organisational silos, avoiding AI bias, adoption hurdles and sustainable funding

9:30am–9:55amMonday

Generate high quality RWD from wearables pre-market access – no longer a pipe dream

  • Understand the support system, such as HCP education on data collection and HCP guidance to patients on correct use, to ensure data generated is accurate
  • Regulatory perspective on changes needed for passive data collection to more commonly impact decision-making
  • See the difference between achieving consumer-grade and medical-grade data collection

Innovative evidence for innovative access

9:30am–9:55amMonday

Creative partnership to bolster post-marketing studies with non-traditional data sources

  • How to work with health systems to cut down manual data input and study resource requirements to allow access to new sources/forms of data such as GP records
  • Combine new data with existing datasets to reconfirm existing evidence Create robust evidence for orphan and rare disease treatments

9:30am–9:55amMonday

Setting the precedent for PRO use in regulatory decision-making – Astellas and FDA case study

9:30am–9:55amMonday

Create robust evidence for orphan and rare disease treatments

  • Overcome challenges finding and recruiting patients by using RWE to inform the recruitment process and trial design
  • Ensure efficient evidence generation by working with authorities early to manage expectations and understand key decision-making factors

9:30am–9:55amMonday

Case study: Effectively demonstrate cost effectiveness – new NICE policy on Quality of Life (QoL)

Innovative pricing solutions showcase

9:30am–9:55amMonday

Case study: Delink volume of sales from reimbursement: NICE & NHS England‘s pioneering subscription initiative incentivising antimicrobial development

  • Focus on payment for added value rather than by volume of sales: How NICE’s new value assessment and reimbursement model will be trialled

9:30am–9:55amMonday

Case study: Next generation HTA: How HTx is implementing new assessment methods that support personalised treatment

  • Understand new methodologies that deliver customised information on drug effectiveness to match the complexities of new personalised treatments (e.g. CAR-T)
  • How the H2020 project HTx is fostering greater adoption of new methodologies through alignment of regulators, HTAs, payers, clinicians and industry around the same standards
  • See how RWD can be combined with RCT to demonstrate real-life drug effectiveness

9:30am–9:55amMonday

Panel: Reform or Revolution? Achieve affordable pricing for curative and predictive medicines

  • Learn how existing CAR-T and gene therapy agreements use RWE to demonstrate the long-term value of their treatments, whilst overcoming data quality deficiencies and methodology challenges
  • Discuss how to engage early with authorities to find flexible performance schemes that share risk fairly between both parties
  • Explore proposals on how to measure the long-term healthcare impact of preventive and curative treatments to satisfy HTA assessment

A new confidence in clinical innovation

9:30am–9:55amMonday

Keynote: Patient-centric trials must be digital trials

  • Use technology to create patient-preferred trials – the trials patients would choose if they could. Integrate new processes to modernize the delivery of development
  • Raise ambitions with more personalized endpoints, align goals with patient advocates and deliver an improved Standard of Care
  • How to devise a shared mission to solve unmet need from the outset, with the FDA and EMA

9:30am–9:55amMonday

Keynote: A digital business model: how clinical and real world data can generate new product types

  • Make data a real asset: see how Sanofi intends to use new data insights that develop top-line revenue in the form of new products
  • Harness endpoints previously not in existence through novel data collection, analytics and methods
  • Achieve ambitions through partnership with major tech companies – without ceding total control

9:30am–9:55amMonday

Panel: A moonshot trial with payers, providers and regulators

  • Pharma companies often cite the requirements of payers, providers and regulators as the reason for rigidity in trial design. Does that excuse still wash?
  • What could a co-created public-private partnership generate in terms of trial design?
  • Examine what’s required to build out a trial infrastructure/regulatory framework in a region that would enable digital trials to be done at scale

9:30am–9:55amMonday

Say yes! Overcome perceived risks for new types of trial with unproven ROI

  • Feel the fear and do it anyway: How to determine an appropriate risk tolerance for pursuing unmet needs and betting on approval
  • Rework organisational responsibilities to break deadlocks, empower and support Clin Ops, and ensure trials are reimagined in a futureproof manner

9:30am–9:55amMonday

Simplify trials for site physicians to enable more complex regimens

  • Site staff aren’t digitally-averse, they are distraction-averse. How to ensure your trials don’t add to the EHR burden through careful management of processes
  • Reduce the complexity of your clinical trials to optimize and fit into the real world: the more sophisticated the treatment, the simpler the trial must be
  • Improve site digital readiness – through creating conditions and understanding for change

9:30am–9:55amMonday

Educate to participate: mass market educational tools which can mobilize and empower your patient community

  • Winning potential trial participants’ hearts and minds through articulating a wider understanding of the clinical process and the normality of participation
  • How to translate a motivated population into a recruited cohort

Go big or go home: prioritize scalability

9:30am–9:55amMonday

Move from local pilot to worldwide trial

  • Examine methods for evaluating pilots and determine resources for scaling
  • Get awesome technology into remote locations: what you need in terms of global support infrastructure to drive a high adoption rate

9:30am–9:55amMonday

Your role in encouraging a harmonized regulatory framework

  • Support the FDA, EMA and others in determining the right evidence framework to ease global standards
  • Forge a pro-active internal partnership with regulatory affairs to enable the smartest, compliant global roll-out
  • Harness the voice of the patient-consumer worldwide to provide authentic, auditable understanding of unmet need

9:30am–9:55amMonday

Build a global digital support network that enables full rollout in multiple territories

  • Find technology providers who can develop and distribute medicines, IoT-type devices, sensors, variables into people's homes in a global setting
  • Build a coalition of partners that ensure your trials deliver effectiveness in new regions

9:30am–9:55amMonday

CROs that can!

  • Locate CROs and suppliers that are determined to create a digital paradigm as default, rather than charge for premium services
  • Work as partners: take more shots on goal by lowering upfront development costs and sharing rewards from trial successes
  • Find the optimum balance between internal and outsourced, enabling external expertise without ceding full control

Shiny new tools: wearables, implantables and software for real-time insight

9:30am–9:55amMonday

Natural Born Collectors – build a cohort of always-on digital health natives

  • Fuse trust and technology as the essential ingredients in more efficient patient recruitment
  • Best practice guidelines in working with hardware and software developers for a new generation of tailored patient apps and devices with real-time data output

9:30am–9:55amMonday

Panel: Towards medical-grade device ubiquity

  • Understand how development of Apple’s ResearchKit and Verily’s Baseline will upend your R&D model in the next five years
  • Make wearables work through improving both quality and quantity of data– and broaden your evidence universe by an order of magnitude

9:30am–9:55amMonday

Build modular handbooks and toolkits to create trial flexibility

  • Create new trials at speed with a toolbox of solutions that can be adapted quickly to each situation
  • How to ensure each tool is robust, tested and improves with use
  • Build-up more sophisticated trial designs, master protocol creation and enable a higher volume of adaptive studies without adding bulk

9:30am–9:55amMonday

Make wearables secure!

  • Understand the implications of a hacked device and impact on patient safety and confidentiality
  • Mitigation techniques and baked-in security standards that you must stay ahead of
  • Consent-as-a-service and the right way to manage user preferences

Data, defragmented

9:30am–9:55amMonday

Leverage AI and data harmonization to for smarter protocol designs

  • Look ahead of design elements which outline the best chance of success by building studies and sites around data when and as needed

9:30am–9:55amMonday

Case study: Develop a digital roadmap for cleaner data and clearer R&D management

  • How to create confidence in strategic decisions through cleaner real-time data and better visibility of your company’s data capabilities
  • Lessons from Novartis’ NERVE implementation, providing total real-time visibility of all trials in play

9:30am–9:55amMonday

Don’t let data lakes become data swamps: how to successfully combine clinical data with genomics, RWE, ePROs and more

  • Mine more comprehensive datasets to reach endpoints that were previously unmeasurable, and gain new utility from surplus data
  • Use protocol simulations to forecast trial performance and enable better site/candidate selection

9:30am–9:55amMonday

Give AI a chance! New insight from pooled datasets

  • Gain confidence in digital epidemiology and analytics through smarter, integrated use of data
  • Combine clinical operations, scientists and IT teams to create a new ‘cross-functional language’ and generate insights from algorithms
  • Go from a typical 10% to an 80% utilization of data collected – use deep ML to gain insights from the vast amount of untapped data collected in trials

9:30am–9:55amMonday

Remove barriers to patient participation by solving the privacy challenge

  • Develop privacy solutions so that data collection methods become burdenless and frictionless
  • CaaS (Consent as a service): champion privacy and take a more nuanced approach to consent in order to work on the same side as the patient

Clinical leadership, organisational reform and new trial models

9:30am–9:55amMonday

Use your C-suite to help middle management adapt to digital trials

  • Learn how the most successful CMOs and R&D Heads are driving bold reforms within clinical operations
  • Give innovation leads full ownership for the initial iterations of value demonstration project, and perform iterations to scale up to portfolio level and bring business leaders alongside

9:30am–9:55amMonday

Make clinical agile

  • Determine which aspects of agile development, scrums and squads can transition successfully to faster clinical trial design and execution
  • Understand the creation of a clinical MVP and how learning metrics can be used to create step improvements in product design

9:30am–9:55amMonday

Create the Uber of Clinical Trials

  • Consider how virtual trials could enable underutilized physicians and nurses to assist with trials
  • Build an online platform that turns human resources into digital PIs, connecting them into integral studies through telemedicine.
  • The merits of decentralizing and enabling trained staff to access research opportunities

9:30am–9:55amMonday

Fill the gaps: a universal system for patient referrals across partners

  • A new way to meet the criteria for existing clinical investigations which are not yet fulfilled

9:30am–9:55amMonday

The online hospital as the home for digital trials

  • Evolve from hybrid trials to a fully digitised ecosystem: create an online hospital
  • One investigator per country: the potential of a remote system using sub-investigators to screen, consent, perform follow-up
  • Increase the number of data-points and trust in data by an order of magnitude: develop real-world evidence from a trial setting
  • Recognize that removing human involvement cuts error rates significantly

The whole world’s a trial

9:30am–9:55amMonday

Fight for better outcomes by crowdsourcing advocacy

  • Make patients aware that you’re pursuing a better potential Standard of Care
  • Find KOLs and patient influencers who can influence the acceptance and reimbursement of new, more ambitious endpoints
  • Recruit reputable sources to increase expectations within the community, and enable them to raise consciousness

9:30am–9:55amMonday

The Digitome: a comprehensive digital representation of human health

  • From sickcare to healthcare: translation of the trial into a personalized and accurate way to measure any deviation from homeostasis
  • Develop an always-on platform that unifies mobile and additional datasets (including EHRs and claims data) to gain a holistic picture without creating a formal trial

9:30am–9:55amMonday

Work with closed-loop health systems to cross RWE with clinical data

  • Hear from Kaiser Permanente, the NHS and other single-payer systems to follow patients longitudinally post-trial and understand comparative effectiveness

9:30am–9:55amMonday

Coming soon: the $20k Trial, built in 48 hours

  • Case Study: an ophthalmology trial using Apple ActiveTasks to build a modular system with ResearchKit
  • Understand the impact of democratizing trial creation through using pre-approved modular building blocks to lower price and time

The innovation stage

9:30am–9:55amMonday

Where is tech innovation bringing real value in healthcare – and how are pharma companies keeping pace?

  • Discover how data analysis is now seen as a core competency and why it can reveal unseen insights to add significant business value
  • Learn how integrating AI, blockchain, XR and other emerging technologies is accelerating productivity and efficiencies across the industry
  • Understand how working with startups can accelerate innovation and foster new ways of working for better overall outcomes
  • Hear why encouraging a culture of experimentation and "failing fast" from the ground up is the key to driving innovation in pharma & healthcare
  • Break down siloes: Learn why fostering cross-functional collaboration is the only way to push new ways of working

9:30am–9:55amMonday

Using AI and blockchain to advance drug discovery & development

  • Find out why combining AI and blockchain can massively shorten times and increase effectiveness in the drug development process
  • Hear why the most valuable data for drug discovery is often hidden in silos or unpublished research and how using the blockchain can counteract this
  • Discover why researchers currently have incentives to hide their work rather than collaborate and how a new paradigm is needed to incentivise all the players in the drug development ecosystem

9:30am–9:55amMonday

Linking AI with advanced validated digital biomarkers to improve patient outcomes

  • Understand how the development of advanced digital biomarkers enables better measurement, monitoring and management of diseases
  • Discover how enhanced data science techniques are helping to HCPs deliver highly personalized healthcare
  • Learn about the key roles AI and machine learning play in discovering and interpreting complex patterns in enormous data sets to create digital biomarkers

9:30am–9:55amMonday

Making healthcare provision more intelligent and personal. Is AI the answer?

  • Find out how AI is helping health care providers access vast data sets of potentially life-saving information
  • Hear best practice on what data can be gathered across millions of patient records across multiple geographical locations, and innumerable and sometimes interconnected health conditions
  • See how AI can help detect and analyze large and small trends from the data and make predictions through machine learning that are designed to identify potential health outcomes
  • What’s next? Where does the technology currently fall short and what new insights will we be able to get as the it advances still further

9:30am–9:55amMonday

How blockchain technology could reinvent the pharmaceutical supply chain

  • Hear the latest on the Innovative Medicines Initiative Programme “Blockchain Enabled Healthcare”, a consortium approach to establish the use of blockchain in the healthcare industry
  • Find out why Novartis see blockchain technologies having the potential to hugely improve third party risk management
  • Learn how agreed and standardised digital identifiers can reduce admin and streamline processes across the entire supply chain
  • Discover where else blockchain is starting to make a real impact on workflows in drug and treatment lifecycles

9:30am–9:55amMonday

XR & digital health – the next frontier

  • Get a high-level overview of the technologies and hardware out there now… and what’s coming next
  • Hear about current capabilities and near-term evolution of XR across enterprise
  • Explore some use cases & initiatives in operation across the pharma & healthcare including in R&D, behavioural health, training & education, remote collaboration, patient care and more
  • Learn about XR integration with other tech i.e. Blockchain, AI, Machine Learning, Eye Tracking and what this means for the adoption of the technologies

9:30am–9:55amMonday

How virtual reality is impacting the treatment of mental health

  • Understand the very real power of virtual reality (VR) to help treat a whole range of mental health conditions
  • Discover how it's already supporting the treatment of depression, phobias and other anxiety disorders
  • Find out how both therapists and patients can benefit from using VR to better choose effective treatment pathways
  • Hear how VR is being best used as a companion treatment alongside traditional medicines and the results clinicians are seeing

9:30am–9:55amMonday

Why advances in immunotherapy is heralding an age of truly personalised cancer treatment

  • Get insight on how new developments in targeted cell therapy have the potential to transform cancer treatment
  • Where are the primary risks? And what’s being done to minimize these and drive improved outcomes?
  • Where are we seeing the biggest breakthroughs – which cancer types, which patient types?